Theracryf Plc (TCF) Ordinary 0.25p

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
TheraCryf signs deal for Ox-1 addiction treatment development
12 May 2025 12:25
(Sharecast News) - TheraCryf announced on Monday that it has entered into a master service agreement with contract research organisation Pharmaron UK to support the development of its Orexin-1 addiction...
Company announcements Announcements
-
Notice of Results and Ox-1 presentation
23 May 2025 07:14
Theracryf
-
Holding(s) in Company
22 May 2025 12:43
Theracryf
-
Director/PDMR Shareholding
22 May 2025 12:22
Theracryf
-
Holding(s) in Company
16 May 2025 13:00
Theracryf
-
Master Service Agreement signed for Ox-1 programme
12 May 2025 07:00
Theracryf
-
Board Appointment, Grant of Options, PDMR Dealing
1 May 2025 07:00
Theracryf
-
Investor webinar
26 March 2025 07:00
Theracryf
-
Holding(s) in Company
21 March 2025 15:55
Theracryf
-
Holding(s) in Company
20 March 2025 15:33
Theracryf
-
Holding(s) in Company
20 March 2025 11:01
Theracryf
-
Holding(s) in Company
19 March 2025 12:10
Theracryf
-
Holding(s) in Company
17 March 2025 14:17
Theracryf
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.